ahlam1399
05-29-2015, 02:31 AM
Heron?s nausea drug meets goal in late-stage trial, shares soar
(Reuters) - Heron Therapeutics Inc said its experimental drug for treating chemotherapy-induced nausea and vomiting (CINV) met its main goal in a late-stage trial.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46bc7614/sc/21/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/1/rc.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/1/rc.htm)
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/2/rc.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/2/rc.htm)
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/3/rc.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/ach.img (http://adchoice.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/ach.htm)http://pi.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2t.imghttp://pi2.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=wt8IT93eYkA:yBf-jw2h1Mo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wt8IT93eYkA:yBf-jw2h1Mo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=wt8IT93eYkA:yBf-jw2h1Mo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wt8IT93eYkA:yBf-jw2h1Mo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=wt8IT93eYkA:yBf-jw2h1Mo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/wt8IT93eYkA
(Reuters) - Heron Therapeutics Inc said its experimental drug for treating chemotherapy-induced nausea and vomiting (CINV) met its main goal in a late-stage trial.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/46bc7614/sc/21/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/1/rc.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/1/rc.htm)
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/2/rc.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/2/rc.htm)
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/3/rc.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2.img (http://da.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/ach.img (http://adchoice.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/ach.htm)http://pi.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2t.imghttp://pi2.feedsportal.com/r/228767793759/u/49/f/654207/c/35217/s/46bc7614/sc/21/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=wt8IT93eYkA:yBf-jw2h1Mo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wt8IT93eYkA:yBf-jw2h1Mo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=wt8IT93eYkA:yBf-jw2h1Mo:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=wt8IT93eYkA:yBf-jw2h1Mo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=wt8IT93eYkA:yBf-jw2h1Mo:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/wt8IT93eYkA